Companies Dominating the Blood Culture Tests Landscape
- Becton, Dickinson and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Cepheid
- Scenker Biological Technology Co., Ltd
- Bio-Rad Laboratories, Inc.
- TERUMO BCT, INC.
- bioMérieux SA
- Accelerate Diagnostics, Inc.
- DiaSorin S.p.A.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Blood Culture Tests Market in 2025 is estimated at USD 7.28 billion.
The global market size was valued at over USD 6.64 billion in 2024 and is expected to expand at a CAGR of around 12%, surpassing USD 28.97 billion revenue by 2037.
Asia Pacific is set to exceed USD 9.56 billion by 2037, driven by increasing antibiotic resistance and demand for accurate diagnostics.
The major players in the market include F. Hoffmann-La Roche AG, Cepheid, Scenker Biological Technology Co., Ltd, Bio-Rad Laboratories, Inc., TERUMO BCT, INC., bioMérieux SA.
